Zhitong Finance App News, Shisi Pharmaceutical Group (02005.HK) issued an announcement. The Group has obtained approval from the China National Drug Administration for the production of phenobibrate choline sustained-release capsules (135mg), which is a Class 4 chemical drug, which is deemed to have passed the consistency evaluation.

Zhitong Finance App News, Shisi Pharmaceutical Group (02005.HK) issued an announcement. The Group has obtained approval from the China National Drug Administration for the production of phenobibrate choline sustained-release capsules (135mg), which is a Class 4 chemical drug, which is deemed to have passed the consistency evaluation.